Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Positive results for Rituxan in multiple sclerosis
The study of 104 patients showed a statistically significant reduction in the number of brain lesions observed on serial MRI scans of the brain in the Rituxan-treated group
The study of 104 patients showed a statistically significant reduction in the number of brain lesions observed on serial MRI scans of the brain in the Rituxan-treated group
“The initiation of this pivotal trial is an important milestone in the development of PDX and has the potential to be a significant driver of the company’s future
The contract is under a master agreement with the National Institutes of Health and funded by the National Institute of Allergy and Infectious Diseases. Current vaccine production methods
Funded by the US Agency for International Development (USAID), the trial was part of an international effort to evaluate microbicides as a tool to reduce the risk of
Under the terms of the transaction, Mylan will purchase 51.5% of Matrix’s shares and then make an open offer to Matrix’s remaining shareholders to acquire up to an
The new agreement, which expands a previous deal, is for all of the Mayo Clinic’s non-prescription intranasal treatments for the condition which work by suppressing non-invasive (so-called “saprophytic”)
In preclinical studies, Heat Shock Protein 90 (Hsp90) and the Hedgehog pathway appear to be implicated in the growth and survival of a broad range of blood-related and
The Orapred product line, which includes Orapred ODT and Orapred is marketed by Alliant Pharmaceuticals under a North American license and acquisition agreement entered into on March 15,
Labopharm said that it intends to commercialize its once-daily tramadol product in key markets globally and is actively engaged in discussions to establish a marketing partnership for Canada.
Ongoing toxicity studies of ChronVac-C delivered using Inovio’s electroporation-based system revealed that the combination induces a humoral response in rabbits that is comparable to results previously observed in